Effect of a reserpine-like agent on the release and metabolism of [3H]NA in cell bodies and terminals

Adler-Graschinsky, 1972, Metabolism of norepinephrine released by phenoxybenzamine in isolated guinea-pig atria, J. Pharm. exp. Ther., 180, 286 Brodie, 1966, Application of steady state kinetics to the estimation of synthesis rate and turnover time of tissue catecholamines, J. Pharmac. exp. Ther., 154, 493 Farah, 1977, Possible physiological significance of the initial step in the catabolism of noradrenaline in the central nervous system of the rat, Naunyn-Schmiedeberg's Archs Pharmac., 297, 119, 10.1007/BF00499921 Filinger, 1981, In vitro release of 3H-noradrenaline by amphetamine from the superior cervical ganglion of the cat, Acta physiol. latinoam., 31, 105 Filinger, 1981, MAO-A and MAO-B in the superior cervical ganglion and in the nictitating membrane of the cat, Gen. Pharmac., 12, 481, 10.1016/0306-3623(81)90074-4 Fischer, 1965, Disposition of norepinephrine-H3 in sympathetic ganglia, J. Pharmac. exp. Ther., 224, 401 Graefe, 1973, Preferential metabolism of (−)3H-norepinephrine through the deaminated glycol in the rat vas deferens, Biochem. Pharmac., 22, 1147, 10.1016/0006-2952(73)90231-1 Kopin, 1962, Metabolism of norepinephrine-H3 release by tyramine and reserpine, J. Pharmac. exp. Ther., 138, 351 Kopin, 1964, Storage and metabolism of catecholamines: The role of monoamine oxidase, Pharmac. Rev., 16, 179 Langer, 1974, Selective metabolic pathways for noradrenaline in the peripheral and in the central nervous system, Med. Biology, 52, 372 Langer, 1975, Metabolism of endogenous noradrenaline, 2, 1 Leitz, 1971, The effect of tyramine, amphetamine and metaraminol on the metabolic disposition of 3H-norepinephrine released from the adrenergic neuron, J. Pharmac. exp. Ther., 178, 464 Nash, 1964, The actions of reserpine, guanethidine and metaraminol on cardiac catecholamine stores, Life Sci., 3, 441, 10.1016/0024-3205(64)90204-8 Snedecor, 1967